PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.31%
Negative revenue growth while MRVL stands at 4.29%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-58.24%
Negative gross profit growth while MRVL is at 3.82%. Joel Greenblatt would examine cost competitiveness or demand decline.
250.00%
EBIT growth above 1.5x MRVL's 8.09%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
250.00%
Operating income growth above 1.5x MRVL's 15.99%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
147.06%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
148.23%
Positive EPS growth while MRVL is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
148.23%
Positive diluted EPS growth while MRVL is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-29.30%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-29.30%
Reduced diluted shares while MRVL is at 1.17%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
53.23%
Maintaining or increasing dividends while MRVL cut them. John Neff might see a strong edge in shareholder returns.
-97.71%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-130.90%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
85.05%
10Y revenue/share CAGR above 1.5x MRVL's 56.20%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
69.30%
5Y revenue/share CAGR at 50-75% of MRVL's 109.65%. Martin Whitman would worry about a lagging mid-term growth trajectory.
41.60%
3Y revenue/share CAGR above 1.5x MRVL's 25.49%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
484.92%
Net income/share CAGR at 50-75% of MRVL's 653.69%. Martin Whitman might question if the firm’s product or cost base lags behind.
-31.93%
Negative 5Y net income/share CAGR while MRVL is 220.76%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-36.89%
Negative 3Y CAGR while MRVL is 202.86%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
158.20%
Stable or rising mid-term dividends while MRVL is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
139.08%
Our short-term dividend growth is positive while MRVL cut theirs. John Neff views it as a comparative advantage in shareholder returns.
0.22%
AR growth is negative/stable vs. MRVL's 11.24%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
1.84%
Inventory shrinking or stable vs. MRVL's 4.05%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-6.19%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
37.76%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
-11.77%
We’re deleveraging while MRVL stands at 3.89%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-9.17%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.